TFP
RMD icon

Tilia Fiduciary Partners’s ResMed RMD Stock Holding History

Tilia Fiduciary Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-68
Closed -$14.9K – 390
2023
Q2 		$14.9K Hold
68
– – 0.01% 334
2023
Q1 		$14.9K Hold
68
– – 0.01% 336
2022
Q4 		$14.1K Hold
68
– – 0.01% 333
2022
Q3 		$15K Buy
68
+1
+1% +$228 0.02% 327
2022
Q2 		$15K Hold
67
– – 0.01% 347
2022
Q1 		$16K Sell
67
-5
-7% -$1.21K 0.01% 355
2021
Q4 		$19K Buy
+72
New +$18.7K 0.02% 344

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Tilia Fiduciary Partners's RMD Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of ResMed (RMD) in Q3 2023, closing a stake of 68 shares — an estimated $14.9K sold.

Tilia Fiduciary Partners first reported a position in RMD in Q4 2021 and held it in 7 quarters. The position peaked at $19K in Q4 2021. 658 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 68 ResMed shares in Q3 2023, an estimated $14.9K.
  • Tilia Fiduciary Partners first reported a position in ResMed in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's ResMed position peaked at $19K in Q4 2021.
  • 658 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.